XML 29 R33.htm IDEA: XBRL DOCUMENT v3.20.1
SUMMARY OF PRINCIPAL ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2019
SUMMARY OF PRINCIPAL ACCOUNTING POLICIES  
Schedule of amounts and balances of the VIEs were included in the Group's consolidated financial statements after the elimination of intercompany balances and transactions

 

 

 

 

 

 

 

 

As of December 31, 

 

    

2018

    

2019

Current Assets:

 

  

 

  

Cash and cash equivalents

 

8,527

 

40,964

Restricted cash

 

 —

 

12,631

Accounts receivable, net

 

28,351

 

60,173

Notes receivable

 

 —

 

23,274

Inventories

 

210,285

 

389,195

Prepayments and other current assets

 

133,655

 

171,318

Total current assets

 

380,818

 

697,555

Property and equipment

 

9,962

 

15,599

Intangible assets, net

 

382

 

774

Long-term investments

 

11,140

 

140

Operating lease right-of-use assets

 

 —

 

67,103

Other non-current assets

 

1,446

 

2,078

Total assets

 

403,748

 

783,249

Current Liabilities:

 

 

 

 

Short-term borrowings

 

 —

 

(65,081)

Accounts payable

 

(211,954)

 

(394,242)

Accrued expenses and other current liabilities

 

(50,356)

 

(149,111)

Total current liabilities

 

(262,310)

 

(608,434)

Long-term operating lease liabilities

 

 —

 

(47,750)

Total liabilities

 

(262,310)

 

(656,184)

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2017

    

2018

    

2019

Net revenues

 

959,153

 

1,785,757

 

3,302,818

Total cost and expenses

 

(930,567)

 

(1,809,656)

 

(3,383,187)

Net income (loss)

 

28,586

 

(23,899)

 

(80,369)

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2017

    

2018

    

2019

Net cash used in operating activities

 

(124,409)

 

(112,425)

 

(263,750)

Net cash used in investing activities

 

(54)

 

(7,308)

 

(4,684)

Net cash provided by financing activities

 

 —

 

 —

 

87,892

 

Schedule of estimated useful lives

 

 

 

 

Leasehold improvements

    

Shorter of the lease term or their estimated useful lives

Furniture, fixtures and equipment

 

3 years

Electronic equipment

 

3 years

Vehicles

 

5 years

 

Schedule of concentration of customers and suppliers

 

 

 

 

 

 

 

 

As of December 31,

 

 

    

2018

    

2019

 

Accounts receivable:

 

 

 

 

 

A

 

*

 

18.8

%

 


The following supplier accounted for 10% or more of purchases for the years ended December 31, 2017, 2018 and 2019:

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2017

    

2018

    

2019

Product purchases:

 

  

 

  

 

  

A

 

14.1

%

13.9

%  

*

B

 

*

 

12.7

%  

*

 

The following suppliers accounted for 10% or more of balances of accounts payable as of December 31, 2018 and 2019:

 

 

 

 

 

 

 

As of December 31,

 

    

2018

    

2019

Accounts payable:

 

 

 

 

A

 

18.9

%

*


*

Less than 10%.

Schedule of product revenues and segment profit/(loss) generated by its segments

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2017

    

2018

    

2019

B2C segment

 

  

 

  

 

  

Product revenues

 

862,327

 

847,476

 

763,254

Cost of products sold*

 

(780,137)

 

(767,073)

 

(654,796)

Segment profit for B2C Business

 

82,190

 

80,403

 

108,458

B2B segment

 

  

 

  

 

  

Product revenues

 

86,890

 

922,751

 

3,166,444

Cost of products sold*

 

(88,582)

 

(914,627)

 

(3,132,074)

Segment (loss) profit for B2B Model

 

(1,692)

 

8,124

 

34,370

Total segment profit

 

80,498

 

88,527

 

142,828


*

For segment reporting purpose, purchase rebate is allocated to B2C segment and B2B segment primarily based on the amount of cost of products sold for each segment. Cost of products sold does not include other direct costs related to cost of product sales such as shipping and handling expense, payroll and benefits of logistic staff, logistic centers rental expenses and depreciation expenses, which are recorded in the fulfillment expenses.

Schedule of reconciliation of reportable segments revenue to the Group's consolidated revenues

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2017

    

2018

    

2019

Total revenues for reportable segments

 

949,217

 

1,770,227

 

3,929,698

Service revenues

 

10,269

 

15,743

 

22,355

Total consolidated revenues

 

959,486

 

1,785,970

 

3,952,053

 

Schedule of reconciliation of the reportable segments' measures of profit or loss to the Group's consolidated loss before income taxes

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2017

    

2018

    

2019

Total profit for reportable segments

 

80,498

 

88,527

 

142,828

Unallocated amounts:

 

  

 

 

 

 

Service Revenues

 

10,269

 

15,743

 

22,355

Fulfillment expenses

 

(55,880)

 

(73,930)

 

(128,996)

Selling and marketing expenses

 

(190,074)

 

(260,040)

 

(340,562)

General and administrative expenses

 

(53,434)

 

(98,759)

 

(123,501)

Technology expenses

 

(48,133)

 

(71,248)

 

(61,902)

Other operating income (expenses), net

 

2,732

 

(668)

 

(3,735)

Interest income

 

4,013

 

4,352

 

4,802

Interest expense

 

(55)

 

 —

 

(3,622)

Foreign exchange  (loss) gain

 

(3,492)

 

2,459

 

(10,328)

Other income (loss),net

 

4,229

 

11,531

 

834

Loss before income tax

 

(249,327)

 

(382,033)

 

(501,827)

 

Schedule of revenues from different product groups and services

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2017

    

2018

    

2019

Product Revenues

 

949,217

 

1,770,227

 

3,929,698

Drugs

 

649,341

 

1,489,917

 

3,595,419

Nutritional supplements

 

123,214

 

190,425

 

245,644

Contact lenses.

 

107,275

 

47,295

 

18,110

Medical supplies and devices

 

49,414

 

26,563

 

50,178

Other products.

 

19,973

 

16,027

 

20,347

Service Revenues

 

10,269

 

15,743

 

22,355

MP Service

 

8,767

 

12,375

 

17,239

Other Services

 

1,502

 

3,368

 

5,116

Total

 

959,486

 

1,785,970

 

3,952,053

 

Schedule of impact on consolidated balance sheet

 

 

 

 

 

 

 

 

    

December 31, 2018

    

January 1, 2019

 

 

 

 

Effect of the adoption

 

 

 

    

As reported

    

 of ASC 842

    

As adjusted

ASSETS

 

  

 

  

 

  

Prepayments and other current assets

 

161,147

 

(1,371)

 

159,776

Operating lease right-of-use assets

 

 —

 

62,408

 

62,408

Total assets

 

1,546,418

 

61,037

 

1,607,455

 

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

  

 

  

 

  

Accrued expenses and other current liabilities

 

102,261

 

19,795

 

122,056

Long-term operating lease liabilities

 

 —

 

41,242

 

41,242

Total liabilities

 

322,654

 

61,037

 

383,691

Total equity

 

1,223,764

 

 —

 

1,223,764

Total liabilities and equity

 

1,546,418

 

61,037

 

1,607,455